Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05423093
Other study ID # IRB00170216
Secondary ID 1K23MH118431-01A
Status Recruiting
Phase N/A
First received
Last updated
Start date June 9, 2022
Est. completion date September 9, 2024

Study information

Verified date December 2023
Source Johns Hopkins University
Contact Rheanna Platt
Phone 410-550-8753
Email rplatt1@jhmi.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of the proposed research is to test the feasibility and acceptability of a virtual group session which is intended to be offered universally to Spanish-speaking parents of newborns/infants attending pediatric primary care. The virtual session is intended to (1) enhance patient/family education about postpartum depression (PPD) and (2) Provide an orientation to families regarding relevant clinic and community psychosocial support resources available. The investigators will conduct a single-arm, open pilot of the session, which will be co-delivered by existing clinic staff (including social work and community outreach staff). Session contents include (1) Introduction to clinic staff, contacts, and resources (2) A video-recorded testimonial of a patient with a history of perinatal depression followed by a group discussion about/reflection on the video; (3) Review of prevalence and signs of PPD; (4) Discussion of clinic PPD screening procedures and rationale for screening; (5) Discussion of self-care and mood monitoring; (6) Discussion of relevant local resources, including information about availability of primary care resources for parents (including uninsured parents) and information about resources addressing social needs. The overall aim of the project is to Develop and pilot a virtual group augmentation of standard individual well-child care to improve (1) clinic screening procedures, discussion about and initial management of maternal depressive symptoms with immigrant Latinas and (2) patient symptom recognition, symptom disclosure, and subsequent treatment engagement


Recruitment information / eligibility

Status Recruiting
Enrollment 32
Est. completion date September 9, 2024
Est. primary completion date November 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years to 99 Years
Eligibility Inclusion Criteria: - Parent participants will be eligible if the preferred healthcare language is Spanish, if they are the mother of an infant (<2 months of age) attending participating pediatric practice, and if she is not felt to have a contraindication to participation (e.g., condition in the parent that would preclude the ability to reasonably participate in a virtual group session) by clinic staff - Clinic staff participants - facilitators of virtual groups Exclusion Criteria: - <16 years old, preferred healthcare language not Spanish, not planning to attend participating practice, clinic staff determines contraindication to participation in group discussion

Study Design


Intervention

Behavioral:
Single-Session Virtual Group Psychoeducational Session about Postpartum Depression
Session contents include (1) Introduction to clinic staff, contacts, and resources (2) A video-recorded testimonial of a patient with a history of perinatal depression followed by a group discussion about/reflection on the video; (3) Review of prevalence and signs of PPD; (4) Discussion of clinic PPD screening procedures and rationale for screening; (5) Discussion of self-care and mood monitoring; (6) Discussion of relevant local resources, including information about availability of primary care resources for parents (including uninsured parents) and information about resources addressing social needs.

Locations

Country Name City State
United States Johns Hopkins Bayview Medical Center Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

References & Publications (4)

Caplan S. A Pilot Study of a Novel Method of Measuring Stigma about Depression Developed for Latinos in the Faith-Based Setting. Community Ment Health J. 2016 Aug;52(6):701-9. doi: 10.1007/s10597-016-0005-7. Epub 2016 Apr 16. — View Citation

Eghaneyan BH, Killian MO, Sanchez K, Cabassa LJ. Psychometric Properties of Three Measures of Stigma Among Hispanics with Depression. J Immigr Minor Health. 2021 Oct;23(5):946-955. doi: 10.1007/s10903-021-01234-3. Epub 2021 Jun 19. — View Citation

Fothergill KE, Gadomski A, Solomon BS, Olson AL, Gaffney CA, Dosreis S, Wissow LS. Assessing the impact of a web-based comprehensive somatic and mental health screening tool in pediatric primary care. Acad Pediatr. 2013 Jul-Aug;13(4):340-7. doi: 10.1016/j.acap.2013.04.005. — View Citation

Weiner BJ, Lewis CC, Stanick C, Powell BJ, Dorsey CN, Clary AS, Boynton MH, Halko H. Psychometric assessment of three newly developed implementation outcome measures. Implement Sci. 2017 Aug 29;12(1):108. doi: 10.1186/s13012-017-0635-3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Satisfaction as assessed by the Intervention Satisfaction Survey 8 items, 5-point likert scale from 1 (strongly disagree) to 5 (strongly agree), higher scores indicative of higher satisfaction. No established cutoff. Completed by parent participants within 2 weeks of attending video group session
Primary Acceptability of intervention Measure 4-question pragmatic measure designed to assess construct of intervention acceptability as perceived by participant. 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available; however, higher scores indicate greater acceptability Completed by parent participants within 2 weeks of attending video group session
Primary Intervention Appropriateness Measure (IAM) 4-question pragmatic measure designed to assess the perceived fit, relevance, or compatibility of an intervention/innovation for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Questions assess the degree to which the respondent agrees with the following statements: (1) "The intervention seems fitting", (2) "The intervention seems suitable"; (3) The intervention seems applicable; (4) The intervention seems like a good match. Possible responses include: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however, higher scores indicate greater perceived appropriateness 1 week
Primary Acceptability of the Intervention as assessed by the Intervention Appropriateness Measure 4-question pragmatic measure designed to assess the perceived fit, relevance, or compatibility of an intervention/innovation for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Questions assess the degree to which the respondent agrees with the following statements: (1) "The intervention seems fitting", (2) "The intervention seems suitable"; (3) The intervention seems applicable; (4) The intervention seems like a good match. Possible responses include: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however, higher scores indicate greater perceived appropriateness 3 months
Primary Intervention Appropriateness Measure (IAM) 4-question pragmatic measure designed to assess the perceived fit, relevance, or compatibility of an intervention/innovation for a given practice setting, provider, or consumer; and/or perceived fit of the innovation to address a particular issue or problem. Questions assess the degree to which the respondent agrees with the following statements: (1) "The intervention seems fitting", (2) "The intervention seems suitable"; (3) The intervention seems applicable; (4) The intervention seems like a good match. Possible responses include: 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however, higher scores indicate greater perceived appropriateness 6 months
Primary Feasibility of Intervention Measure 4-question pragmatic measure designed to assess construct of intervention feasibility. 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however higher scores indicate greater perceived feasibility 1 week
Primary Feasibility of Intervention Measure 4-question pragmatic measure designed to assess construct of intervention feasibility. 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however, higher scores indicate greater perceived feasibility 3 months
Primary Feasibility of Intervention Measure 4-question pragmatic measure designed to assess construct of intervention feasibility. 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree. Cut-off scores for interpretation are not yet available, however, higher scores indicate greater perceived feasibility 6 months
Secondary Change in mental health care stigma as assessed by the Stigma Concerns about Mental Health Care (SCMHC) scale The SCMHC is a 3-item measure assessing stigma-related barriers to the utilization of depression treatment (internalized stigma, fear of stigmatization, and stigma from family in seeking mental health care). Responses are coded as (0) disagree, (1) agree, and (7) don't know/refuse. Respondents receive one point for each response of "agree," which indicates agreement with the stigma-related barrier. The total scores range from 0 to 3 with
higher scores indicating an increased internalization of stigma to mental health care
Completed by parent participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session
Secondary Change in Depression Stigma as assessed by the Adapted Personal Stigma Scale (PSS) 7 items, assess personal attitudes towards people with depression. Items answered on 5-point Likert scale ranging from 0 (strongly disagree) to 4 (strongly agree). Total scores range from 0 to 28, higher scores indicating higher levels of personal depression stigma Completed by participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session
Secondary Change in Postpartum Depression Knowledge as assessed by Adapted Postpartum Depression Knowledge Measure Measure of participant knowledge about postpartum depression knowledge- adapted and translated from the Ontario Rapid Risk Factor Surveillance Survey. Questions include whether the participant has heard of the concept of postpartum depression, asks participants to name symptoms of postpartum depression, and asks participants how common they would estimate the condition to be. There is no standard scale/scoring. Completed by participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session
Secondary Change in Intention to disclose if developed postpartum depression symptoms as assessed by questionnaire Single-question item: If I felt down, depressed, hopeless, or having little interest or pleasure in doing things I would try to contact someone at this clinic. Responses are no (0) and Yes (1) Completed by parent participants at baseline (pre-session); within 2 weeks post-session; and 6 months post-session
Secondary Intention to seek primary care as assessed by questionnaire Developed for this study, single likert scale question, asked of participants who did not have an identified primary care doctor at baseline: As a result of the video group session, I plan to identify a doctor that I can see regularly for my own check-ups. Adapted from National Latino and Asian American Study completed within 2 weeks of attending video group session.
Secondary Mental health utilization as assessed by the Mental Health Service Utilization Single item, adapted from National Latino and Asian American Study Baseline, 6 months post-intervention (completed by parent)
Secondary Psychosocial Resource Utilization as assessed by questionnaire Question developed for this project and translated/certified, assessing use of clinic ancillary services discussed in the intervention: In the past 2 months, have you used any of the resources that were discussed in the video session or on the clinic website? 6-months post-intervention, completed by participant
See also
  Status Clinical Trial Phase
Recruiting NCT06348316 - Early Half Swaddling and Kangaroo Care Practices on Maternal Sleep Quality and Postpartum Depression in Term Babies N/A
Recruiting NCT05322161 - Yoga in the NICU for Parents Study N/A
Withdrawn NCT03709004 - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression N/A
Completed NCT06305325 - Coparenting Intervention to Prevent Postpartum Depression N/A
Not yet recruiting NCT05055674 - The Effects of Motherly on Postpartum Depression N/A
Enrolling by invitation NCT02323152 - PREVENTION OF POSTPARTUM DEPRESSION DEVELOPMENT IN WOMEN WITH VERY HIGH RISK N/A
Not yet recruiting NCT01658098 - Prevalence of Postpartum Depression in Hospital Jose E. Gonzalez N/A
Completed NCT00961402 - The Effect of Exercise on Preventing PostPartum Depression Phase 2
Completed NCT01312883 - Mothers Avoiding Depression Through Empowerment Intervention Trial N/A
Completed NCT00360204 - Improving Health Outcomes for New Mothers and Babies Phase 3
Unknown status NCT00548743 - Translating Research Into Practice for Postpartum Depression N/A
Completed NCT04146025 - Nurtured in Nature N/A
Recruiting NCT05137925 - Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum N/A
Not yet recruiting NCT05299398 - Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone Phase 1
Completed NCT04925765 - Virtual Reality Biofeedback for Postpartum Anxiety and Depression N/A
Recruiting NCT06053515 - Rosie the Chatbot: Leveraging Automated and Personalized Health Information Communication N/A
Completed NCT04037085 - Ketamine to Improve Recovery After Cesarean Delivery - Part 1 Phase 2
Completed NCT05059600 - A Study To Assess The Safe-Use Conditions For Administration of ZULRESSO® in a Home Setting Phase 4
Completed NCT06136520 - The Effect of Baby Massage Training Given to Pregnant Women on Maternal Attachment and Postpartum Depression N/A
Recruiting NCT05038085 - Postpartum Depression and Maternal Attachment N/A